---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-096474"
form_type: "8-K"
ticker: "FBLG"
cik: "0001958777"
company_name: "FibroBiologics, Inc."
filed_at: "2026-03-06T23:59:59+00:00"
generated_at: "2026-05-15T19:01:40.272376+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# FibroBiologics raises CFO Jason D. Davis base salary to $400,000

## Summary
- CFO Jason D. Davis annual base salary increased to $400,000, effective January 1, 2026.
- Target non-equity incentive compensation remains at 40% of base salary.
- No other changes to CFO compensation or role were disclosed.

## SEC filing metadata
- accession: 0001193125-26-096474
- form_type: 8-K
- ticker: FBLG
- cik: 0001958777
- company_name: FibroBiologics, Inc.
- filed_at: 2026-03-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1958777/000119312526096474/0001193125-26-096474-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1958777/000119312526096474/fblg-20260304.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-096474
- JSON: https://secwatch.observer/filing/0001193125-26-096474.json
- Plain text: https://secwatch.observer/filing/0001193125-26-096474.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.